Theon International: Investor Webcast on July 9 Following the Acquisition of HGH for €300M
Theon International will host an investor webcast on July 9 to detail its financial strategy and recent developments, including the acquisition of HGH Systèmes Infrarouges for approximately €300M. This presentation comes two weeks before the announcement of its second-quarter results.
A Web Conference to Clarify Trajectory and HGH Acquisition
The Greek manufacturer of thermal imaging and night vision systems will host a session on July 9 at 11 AM (British time) for dialogue with investors via the Investor Meet Company platform. Philipe Mennicken, Deputy CEO and Director of Business Development, and Dimitris Parthenis, Chief Financial Officer, will present recent developments and the financial outlook of the group. This intervention will also discuss the recently announced strategic acquisition of SAS Stéropès, the holding company controlling HGH Systèmes Infrarouges.
The webcast will include a live Q&A session and will welcome current and potential investors, as well as other market participants. Questions can be submitted before the event or live during the session via the platform.
A Major Acquisition to Strengthen Thermal Offering
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Theon International has reached an agreement to acquire SAS Stéropès for an enterprise value of approximately €300M. This transaction involves HGH Systèmes Infrarouges, a provider of thermal imaging systems. The acquisition aligns with the group's development objectives, which already operates in more than 10 countries and has over 280,000 systems in service with armed and specialized forces in 72 countries, including 26 NATO members.
In 2025, Theon won the largest public tender for night vision goggles in the history of a NATO member state, a contract for more than 100,000 units for the Belgian and German armed forces, valued at approximately €1 billion.
Strong H1 performance and positive momentum continuing into H2 2026 with further acceleration expected in Q4.
Risks mentioned
Integration of newly acquired businesses represents execution risk
Market expansion into high-growth adjacencies requires successful product development and market acceptance
Working capital absorption at 40% of LTM revenues indicates continued working capital pressure
Opportunities identified
Expansion into high-growth adjacencies increasing addressable market to nearly €8 billion
Integration of newly acquired businesses to drive future growth
Strong seasonal second half weighting supporting continued momentum into Q4 2026
Outlook / guidance
Expected revenue: 600 millions d'euros
Management commentary: THEON's Management team will also provide an update on FY 2026 and medium-term guidance during the webcast tomorrow. FY 2026 Guidance: Revenue c.€600 m; Adjusted EBIT Margin >26%; Capex €30 m; Medium-Term: Organic Growth >15%p.a.; Capex c. 4% of Revenue.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
